Prepare for the CAMLPR Specimen Collection Competency Test. Practice with diverse question sets including multiple-choice and flashcards. Each question includes hints and explanations to help you become proficient before the exam.

Multiple Choice

In which situation would an RhIG work-up be ordered?

RhIG work-up is about determining the mother’s Rh status and whether she has anti-D antibodies, so the decision to give Rh immune globulin depends on the mother’s own status and antibody screen, not on a single pregnancy scenario or the partner’s status. Because a mother could become sensitized if exposed to Rh-positive fetal cells at any time (during pregnancy, delivery, or obstetric procedures), the appropriate lab step is to assess her Rh type and antibody status in any woman who could become pregnant. That’s why this work-up would be ordered for a mother regardless of pregnancy status. If she is Rh-negative and has not developed anti-D antibodies, RhIG prophylaxis may be indicated after sensitizing events or during pregnancy; if antibodies are present, alternative management is needed. The other options point to specific paternal or fetal statuses, which don’t capture the universal approach to screening a mother’s Rh status and antibodies that guides RhIG use.

RhIG work-up is about determining the mother’s Rh status and whether she has anti-D antibodies, so the decision to give Rh immune globulin depends on the mother’s own status and antibody screen, not on a single pregnancy scenario or the partner’s status. Because a mother could become sensitized if exposed to Rh-positive fetal cells at any time (during pregnancy, delivery, or obstetric procedures), the appropriate lab step is to assess her Rh type and antibody status in any woman who could become pregnant. That’s why this work-up would be ordered for a mother regardless of pregnancy status. If she is Rh-negative and has not developed anti-D antibodies, RhIG prophylaxis may be indicated after sensitizing events or during pregnancy; if antibodies are present, alternative management is needed. The other options point to specific paternal or fetal statuses, which don’t capture the universal approach to screening a mother’s Rh status and antibodies that guides RhIG use.